Adverum Biotechnologies ADVM
$ 4.7
0.0%
Quarterly report 2024-Q3
added 11-04-2024
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Ms. Leone Patterson |
Employees in the company |
114 |
Shares |
101 M |
Market Cap[1] |
$ 474 M |
EBITDA (LTM) |
$ -132 M |
P/E (LTM) |
-1.08 |
P/S (LTM) |
- |
EPS (LTM) |
-6.95 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.